Journal article

Safety and efficacy of whole-body chlorhexidine gluconate cleansing with or without emollient in hospitalised neonates (NeoCHG): a multicentre, randomised, open-label, factorial pilot trial

Abstract:: Background
Healthcare-associated infections account for substantial neonatal in-hospital mortality. Chlorhexidine gluconate (CHG) whole body skin application could reduce sepsis by lowering bacterial colonisation density, although safety and optimal application regimen is unclear. Emollients, including sunflower oil, may independently improve skin condition, thereby reducing sepsis. We aimed to inform which concentration and frequency of CHG, with or without emollient... Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Russell, N., Clements, M. N., Azmery, K. S., Bekker, A., Bielicki, J., Dramowski, A., Ellis, S., Fataar, A., Hoque, M., LeBeau, K., O'Brien, S., Schiavone, F., Skoutari, P., Islam, M. S., Saha, S., Walker, A. S., Whitelaw, A., & Sharland, M. (2024). Safety and efficacy of whole-body chlorhexidine gluconate cleansing with or without emollient in hospitalised neonates (NeoCHG): a multicentre, randomised, open-label, factorial pilot trial. EClinicalMedicine, 69.

MLA Style

Russell, N, et al. “Safety and Efficacy of Whole-Body Chlorhexidine Gluconate Cleansing with or without Emollient in Hospitalised Neonates (NeoCHG): a Multicentre, Randomised, Open-Label, Factorial Pilot Trial.” EClinicalMedicine, vol. 69, 2024.

Chicago Style

Russell, N, MN Clements, KS Azmery, et al. 2024. “Safety and Efficacy of Whole-Body Chlorhexidine Gluconate Cleansing with or without Emollient in Hospitalised Neonates (NeoCHG): a Multicentre, Randomised, Open-Label, Factorial Pilot Trial.” EClinicalMedicine 69.
Print

Access Document

Files:: Russell_et_al_2024_Safety_and_efficacy.pdf

(Preview, Version of record, pdf, 672.0KB, Terms of use)

Publisher copy:: 10.1016/j.eclinm.2024.102463

Authors

+ Russell, N More by this author

Role:: Author

+ Clements, MN More by this author

Role:: Author

+ Azmery, KS More by this author

Role:: Author

+ Bekker, A More by this author

Role:: Author

+ Bielicki, J More by this author

Role:: Author

More authors...

Publisher:: Elsevier
Journal:: EClinicalMedicine More from this journal
Volume:: 69
Article number:: 102463
Publication date:: 2024-02-25
Acceptance date:: 2024-01-17
DOI:: 10.1016/j.eclinm.2024.102463
EISSN:: 2589-5370

Language:: English
Keywords:: antiseptic

neonatal sepsis

infection prevention
Pubs id:: 1602508
Local pid:: pubs:1602508
Deposit date:: 2024-01-18
ARK identifier:: ark:/29072/ora_72269119b06849829a6abeb203dc770e

Terms of use

Copyright holder:: Russell et al
Copyright date:: 2024
Rights statement:: © 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

Licence:: CC Attribution (CC BY)

Views and Downloads

Views and downloads will return soon

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP